Renal failure in a depressed adolescent on escitalopram

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 4, 2008, Pages 405-408

  Miriyala, Kalpana ^a   Coffey, Barbara ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ESCITALOPRAM; METOCLOPRAMIDE;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADOLESCENT; ANXIETY DISORDER; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DEPRESSION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BIOPSY; MENTAL HEALTH; NAUSEA; VOMITING;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; NEPHRITIS, INTERSTITIAL;

EID: 50849125425     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.1842     Document Type: Article

References (13)

1. Agarwal N, Phadke KD, Garg I: Acue renal failure in children with idiopathic nephritic syndrome. Pediatr Nephrol 18:1289-1292, 2003.
2. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson J: Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205-1215, 2002.
3. Forrester MB: Escitalopram ingestions reported to Texas poison control centers, 2002-2005. Hum Exp Toxicol 26:473-482, 2007.
4. Hughes CW, Emslie GJ, Crismon ML, Posner K, Birmaher B, Ryan N, Jensen P, Curry J, Vitello B, Lopez M, Shon SP, Pliska SR, Trivedi: Texas Children's Medication Algorithm Project: Update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry 46:667-686, 2007.
5. Kelly CA, Upex A, Spencer EP, Flanagan RJ, Bateman DN. Adult respiratory distress syndrome and renal failure associated with citalopram overdose. Hum Exp Toxicol 22:103, 2003.
6. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J, and the Treatment for Adolescents with Depression Study (TADS) Team: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292:807-820, 2004.
7. Owley T, Walton L, Salt J, Guter SJ Jr, Winnega M, Leventhal BL, Cook EH Jr: An open-label trial of escitalopram in pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 44:343-248, 2005.
8. Rao N: The clinical pharmacokinetics of escitalopram. Clin Pharmacokinet 46:281-90, 2007.
9. Schaller JL, Rawlings DB: Escitalopram in adolescent major depression. Med Gen Med 7:6, 2005.
10. Thomsen PH, Ebbesen C, Persson C. Long-term experience with citalopram in the treatment of adolescent OCD. J Am Acad Child Adolesc Psychiatry 40:895-902, 2001.
11. Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 45:280, 2006.
12. Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Hevdorn WE: A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psych 161:1079-1083, 2004.
13. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D, for the Sertraline Pediatric Depression Study Group: Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. 290:1033-1041, 2003.